Question 1

What is the catalog number for Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide?

Accepted Answer

The catalog number for Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide is M2E17-P.

Question 2

What sizes are available for Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide?

Accepted Answer

Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide is available in the following size(s): 100 µg.

Question 3

Is Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide in stock?

Accepted Answer

Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 5

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 6

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide

Product Specifications

Frequently Asked Questions

Explore Other Products

IGLV7-46 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

Angiopoietin 1 (ANGPT1) Antibody

Angiopoietin 1 (ANGPT1) Antibody

Angiopoietin 1 (ANGPT1) Antibody

Clstn2 (NM_134377) Rat Tagged ORF Clone

AACS sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)